Association of HLA‐DP/DQ, STAT4 and IL‐28B variants with HBV viral clearance in Tibetans and Uygurs in China
Authors:
- 19 July 2014
- journal article
- viral hepatitis
- Published by Wiley in Liver International
- Vol. 35 (3) , 886-896
Abstract
Background & Aims: Several genome‐wide association studies have revealed that HLA‐DP/DQ, STAT4 and IL‐28B associated with liver diseases. But because of population heterogeneity, different races would have different causative polymorphisms. Therefore, in this study, we included Chinese Tibetans and Uygurs to examine the roles of these genes on HBV natural clearance.Methods: A total of 1341 subjects including 908 Tibetans and 433 Uygurs were recruited. Seven single nucleotide polymorphisms (SNP) were genotyped.Results: HLA‐DP/DQ polymorphisms associated with HBV natural clearance in both ethnicities (Tibetans, rs3077, OR = 0.61, 95% CI = 0.46–0.82; rs9277535, OR = 0.56, 95% CI = 0.41–0.75; rs7453920, OR = 0.64, 95%CI = 0.47–0.85; Uygurs, rs3077, OR = 0.48, 95% CI = 0.24–0.96; rs9277535, OR = 0.43, 95% CI = 0.20–0.91; rs7453920, OR = 0.62, 95% CI = 0.39–0.99), whereas no significant association was observed between IL‐28B with HBV natural clearance in neither ethnicities (P > 0.05). STAT4 rs7574865 seemed to be Tibetan specific in HBV natural clearance (OR = 0.76, 95% CI = 0.58–0.99). Moreover, in Tibetan patients, HLA‐DQ rs7453920 GG had a higher frequency in HBeAg positive patients (P = 0.032) and STAT4 rs7574865 GG genotype appeared more frequently in Genotype C virus infected patients (P = 0.005). In addition, Uygurs have higher frequencies of HLA‐DP/DQ protective alleles (72.5% for rs3077, 76.6% for rs9277535 and 26.8% for rs7453920) than Tibetans (51.7% for rs3077, 52.5% for rs9277535 and 18.5% for rs7453920)(all P < 0.05), and a lower prevalence of HBV infection as previously reported.Conclusions: HLA‐DP/DQ but not IL‐28B polymorphisms correlate with HBV natural clearance, irrespective of race, and HLA‐DP/DQ would be causative genes attributing to varying prevalence in different regions. STAT4 rs7574865 seemed to be population specific in Tibetans and it might synergistically interact with virus contributing to disease progression.Keywords
Funding Information
- Natural Science Foundation of China (81072443, 81100536, 81273256)
This publication has 35 references indexed in Scilit:
- HLA-DP and IL28B Polymorphisms: Influence of Host Genome on Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis BClinical Infectious Diseases, 2013
- Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus–related hepatocellular carcinomaNature Genetics, 2012
- Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma developmentHepatology, 2012
- Polymorphisms Near IL28B and Serologic Response to Peginterferon in HBeAg-Positive Patients With Chronic Hepatitis BGastroenterology, 2012
- A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese populationHuman Molecular Genetics, 2011
- Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese populationHepatology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in AsiansNature Genetics, 2009
- Viral hepatitis BThe Lancet, 2003